Dr. Susan Y. Chen is an Associate of Decheng Capital and has been with the firm since August 2021.
Prior to joining the fund, she was a Consultant at L.E.K. Consulting, where she focused on life sciences strategy, including R&D project selection, business opportunity assessment, and M&A diligence. Dr. Chen received her PhD from the University of California, San Francisco, where she was an NSF graduate research fellow studying synthetic and systems biology. She earned dual B.S. and B.A. degrees in bioengineering and molecular biology from UC Berkeley. Dr. Chen has published seven peer reviewed articles on engineering molecular tools for cellular control, including engineered enzymatic scaffolds, optogenetic control of protein localization, modeling gene expression dynamics and methods for biological feedback control.